Särnstrand B, Tunek A, Sjödin K, Hallberg A
Department of Pharmacology, Astra Draco AB, Lund, Sweden.
Chem Biol Interact. 1995 Feb;94(2):157-64. doi: 10.1016/0009-2797(94)03332-3.
The effects of the stereoisomers of N-acetylcysteine (L-NAC and D-NAC) on oxygen-induced lung oedema have been studied in rats. The NAC-isomers were given by an osmotic minipump in order to attain continuous administration, either intravenously or intragastrically. In some experiments, plasma concentrations of NAC, cysteine and glutathione (total concentrations, i.e., concentrations obtained after reduction of the samples with dithiothreitol) were recorded. Exposure to oxygen induced an almost two-fold increase of the lung wet weight. When L-NAC or D-NAC were given intravenously, in dose of 1.1 mmol/day/kg body weight, the increase of lung wet weight was prevented by 40-50%. The plasma concentrations were approximately 40 microM (L-NAC) and approximately 90 microM (D-NAC). Following intragastrical administration of the same doses, plasma concentrations of L-NAC and D-NAC reached approximately 3 and approximately 60 microM, respectively. Using this method of administration, only D-NAC significantly diminished the increase of the lung wet weight. The difference in plasma concentrations of the NAC isomers, particularly after intragastric administration, most likely reflects the fact that L-NAC is effectively hydrolysed in most tissues, while D-NAC is resistant to enzymatic hydrolysis, thus penetrating largely intact into the systemic circulation. The data presented shows that NAC, regardless of stereoconfiguration, will protect the lung against oxygen toxicity, provided sufficient systemic levels are obtained. Since D-NAC is not a precursor of L-cysteine, formation of glutathione cannot explain the protective effects of this isomer. L- and D-NAC may therefore act via direct antioxidant/radical scavenging mechanisms and not necessarily as precursors of glutathione in this model.
已在大鼠中研究了N-乙酰半胱氨酸的立体异构体(L-NAC和D-NAC)对氧诱导的肺水肿的影响。通过渗透微型泵给予NAC异构体,以实现静脉内或胃内的持续给药。在一些实验中,记录了NAC、半胱氨酸和谷胱甘肽的血浆浓度(总浓度,即样品用二硫苏糖醇还原后获得的浓度)。暴露于氧气会导致肺湿重增加近两倍。当以1.1 mmol/天/千克体重的剂量静脉内给予L-NAC或D-NAC时,肺湿重的增加被阻止了40-50%。血浆浓度分别约为40μM(L-NAC)和约90μM(D-NAC)。以相同剂量胃内给药后,L-NAC和D-NAC的血浆浓度分别达到约3μM和约60μM。使用这种给药方法,只有D-NAC显著减少了肺湿重的增加。NAC异构体血浆浓度的差异,特别是胃内给药后,很可能反映了这样一个事实,即L-NAC在大多数组织中被有效水解,而D-NAC对酶促水解具有抗性,因此大部分完整地进入体循环。所呈现的数据表明,只要获得足够的全身水平,无论立体构型如何,NAC都能保护肺免受氧毒性。由于D-NAC不是L-半胱氨酸的前体,谷胱甘肽的形成不能解释这种异构体的保护作用。因此,在这个模型中,L-NAC和D-NAC可能通过直接的抗氧化/自由基清除机制起作用,而不一定作为谷胱甘肽的前体。